08 March 2021
: Case report 
Activated Prothrombin Complex Concentrate-Induced Atypical Hemolytic Uremic Syndrome Treated with Eculizumab
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Unexpected drug reaction
Hsin Hsiang Clarence Tsai1CDEF*, Justin Tyler Moyers2BCDE, Christie J. Moore3BE, MieMie Thinn4DEDOI: 10.12659/AJCR.929616
Am J Case Rep 2021; 22:e929616
Figure 1. Hemoglobin and platelet count over time by day of admission during hospital course along with temporal relationship of therapeutic interventions (FEIBA, Steroids, Plasma Exchange [PLX], and eculizumab). Each point represents a lab value measurement.